News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Cartagenia n.v. Continues Expansion in North American Market -- Announces Two New Canadian Customers

5/16/2012 9:28:10 AM

Leuven, 16 May 2012 – Cartagenia, the world leader in providing diagnostic knowledge, analytic software and database systems to genetic labs and clinicians for patient-centric high-throughput variant assessment and clinical reporting, announces that it has signed contracts with two Canadian customers, including Mississauga, Ontario-based Credit Valley Hospital.

Credit Valley Hospital laboratory is one of two Ontario provincial clinical cytogenetic laboratories designated for postnatal diagnostic arrays and is using the Cartagenia BENCH lab CNV product for fast, standardized triage and classification of copy number variants identified by their Array CGH assays. With BENCH, they are building an internal database of genotype and clinical phenotype findings to quickly classify relevant findings, and automate clinical reporting.

Marsha Speevak, Laboratory Geneticist at Credit Valley Hospital: “Cartagenia was known to us; however, it was not until last December that we began to look at their products in detail. After an in depth evaluation of the platform we quickly concluded that it was ideal for our needs, both today and in the future.”

Cartagenia also signed an agreement with a private genetics lab servicing diagnostic referrers with a growing number of pre-natal and peri-natal assays. The lab will be using BENCH lab CNV for interpretation of Array CGH assay results in the context of patient phenotype, to automatically detect and flag known syndromes and to tailor the platform to automatically generate clinical reports.

These two customer mark the entry of Cartagenia into the Canadian market, shortly after opening its North American office in Cambridge MA in March of this year.

Herman Verrelst, CEO of Cartagenia: “We are very pleased to be able to work with these two labs in Canada. Canada is an important market for us. Many Canadian labs and hospitals have been introducing Array CGH technology in clinical diagnostic use. Cartagenia is there to help these labs cope with the data interpretation challenges that accompany high-throughput genomic technologies. In addition, as an increasing number of genetics labs are also validating Next-Generation Sequencing for use in diagnostic procedures, we have recently introduced a series of products and services to support NGS variant analysis and interpretation. Cartagenia has the only platform for both cyto- and molecular genetic data interpretation. Early feedback has been extremely positive and generated huge interest for our products.”

About Cartagenia

Cartagenia supplies diagnostic knowledge, software and database systems, and related services to genetic labs and clinicians, enabling them to perform clinically relevant genetic analyses quickly and efficiently, and offer patients and carers high-quality genetic interpretation and counselling.


About Credit Valley Hospital

The Credit Valley Hospital’s genetics team provides genetics consultation services to the Halton-Peel region and surrounding communities. The Credit Valley array laboratory is one of two Ontario provincial clinical cytogenetic laboratories designated for postnatal diagnostic arrays. The Genetics team is dedicated to providing patients with respectful and considerate care in a supportive environment.

The CVH Genetics Team is made up of Geneticists, Genetic Counsellors and support staff and works very closely with the other specialties in the hospital such as Maternal Child Services and Oncology, as well as other healthcare providers in the hospital and throughout the community to ensure patients’ individual needs are addressed.



Drew Arnold

VP Sales and Business Development North-America

485 Massachusetts Avenue Suite 300

Cambridge, MA 02139-4018 , USA

T +1 617 475 5105



Herman Verrelst

CEO Cartagenia

Technologielaan 3

3001 Leuven


T +32 16 40 40 66


Read at

comments powered by Disqus